Peroneal Nerve Neuromodulation for Overactive Bladder: A Pilot Study Assessing Efficacy and Safety in Patients with Multiple Sclerosis
APU Journal · 16.05.2026 · 40 (1) · 15-22
DOI: 10.24915/apuj.257 ↗Kurz gefasst
Fachartikel in der Zeitschrift APU Journal, online erschienen am 16.05.2026. Verfasst von Sara Freixo und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Overactive bladder (OAB) symptoms are highly prevalent among patients with multiple sclerosis (MS), significantly impairing quality of life. Peroneal nerve neuromodulation (PNM) has emerged as a potential alternative to posterior tibial nerve stimulation for managing refractory OAB symptoms, although no studies to date have directly evaluated its effects in MS patients. We aimed to assess the clinical and urodynamic effects of transcutaneous peroneal nerve neuromodulation in patients with MS and neurogenic OAB.
Methods
This prospective single-center open-label pilot study included 18 patients with MS and OAB symptoms refractory or intolerant to first-line treatments. Participants received weekly transcutaneous PNM for 12 weeks. Outcomes included changes in urgency episodes (OAB-SF), symptom severity and impact in quality of life (ICIQ-OAB), and urodynamic parameters. Data were analyzed using paired statistical tests ( < 0.05).
Results
Statistically significant improvements were observed in urgency-related items of the OAB-SF and ICIQ-OAB questionnaires, reflecting reduced symptom burden and increased bladder control. Urodynamic data revealed a significant increase in maximum cystometric capacity ( = 0.041), with a trend toward improved urgency volume ( = 0.053). One mild adverse event (local skin burn) was reported and resolved spontaneously. No other adverse effects occurred.
Conclusion
Peroneal nerve neuromodulation appears to be a safe and potentially effective intervention for improving urgency and bladder storage capacity in MS patients with OAB. These findings support further investigation in larger, controlled studies with longer follow-up and functional neuroimaging to better understand therapeutic mechanisms and long-term outcomes.
Zitieren
APA
Freixo, S., Pereira, P., Sousa, J. E., Martins, C. B., & Coelho, M. M. (2026). Peroneal Nerve Neuromodulation for Overactive Bladder: A Pilot Study Assessing Efficacy and Safety in Patients with Multiple Sclerosis. APU Journal, 40(1), 15-22. https://doi.org/10.24915/apuj.257
Vancouver
Freixo S, Pereira P, Sousa JE, Martins CB, Coelho MM. Peroneal Nerve Neuromodulation for Overactive Bladder: A Pilot Study Assessing Efficacy and Safety in Patients with Multiple Sclerosis. APU Journal. 2026;40(1):15-22. doi:10.24915/apuj.257
BibTeX
@article{Freixo2026,
author = {Freixo, Sara and Pereira, Patrícia and Sousa, João Esteves and Martins, Cátia Barbosa and Coelho, Manuela Mira},
title = {Peroneal Nerve Neuromodulation for Overactive Bladder: A Pilot Study Assessing Efficacy and Safety in Patients with Multiple Sclerosis},
journal = {APU Journal},
year = {2026},
volume = {40},
number = {1},
pages = {15--22},
doi = {10.24915/apuj.257}
}
EUVIMED